Broken out by business lines, Symmetry Medical’s implant products gained $25.6 million this quarter, which is down 4 percent compared to the same period last year. The year-over-year revenue increase was driven by growth in the company’s OEM solutions and Symmetry Surgical segments.
More Articles on Orthopedic Devices:
Smith & Nephew Launches Endobutton
DSM, AxioMed Partner for Freedom Spine Device
MiMedx 3Q Revenue Grows 270% to $8M
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.